The recent instability in global chains have highlighted the necessity of securing essential medications like Ivermectin. Dependence on overseas producers exposes nations to significant vulnerabilities, including shipping delays, expense fluctuations, and even trade risks. Shifting towards domestic procurement of Ivermectin offers a multitude of up